BNGO Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
BNGO is not a good buy right now for a beginner long-term investor with $50,000-$100,000 to deploy. The stock shows a weak technical setup, deteriorating recent financial performance, no positive news catalyst, and no strong institutional or insider accumulation. Despite a Buy rating from one analyst, the price target was cut and the Wall Street view is not strong enough to outweigh the bearish trend. Given the user's impatience and unwillingness to wait for a better entry, the direct answer is to avoid buying and not commit capital here.
Technically, BNGO is weak. MACD histogram is negative and worsening, indicating downside momentum. RSI_6 at 31.6 is near oversold but not a clear reversal signal. The moving average structure is bearish, with SMA_200 > SMA_20 > SMA_5, which confirms a downtrend across short, medium, and long horizons. Price at 1.155 is below the pivot level of 1.236 and sitting near S1 at 1.167, showing it is trading under pressure. The stock trend model also points to negative follow-through over the next day, week, and month.
No recent news in the last week. The only modest positives are a small pre-market uptick, a slightly improved gross margin year over year, and the fact that one analyst still keeps a Buy rating.
Revenue fell 2.60% YoY in the latest quarter, net income worsened sharply, and EPS declined steeply. Technical momentum is bearish, there is no recent news catalyst, no meaningful hedge fund or insider buying trend, and no congress trading data indicating interest. The analyst price target was also lowered from $7 to $6.
Latest reported quarter: 2025/Q4. Revenue was $7.95M, down 2.60% YoY. Net income was -$7.93M, down 60.58% YoY. EPS was -0.77, down 93.70% YoY. Gross margin improved to 42.75%, up 2.13% YoY. Overall, profitability and earnings quality remain weak despite a margin improvement.
H.C. Wainwright lowered its price target to $6 from $7 on 2026-04-13 and maintained a Buy rating. This is still positive on rating, but the target cut reflects weaker fundamentals and increased share count. Overall Wall Street pros view is mixed: one supportive Buy, but with reduced conviction and no broad bullish revision trend.
